Literature DB >> 8829715

Immigrant families coping with schizophrenia. Behavioral family intervention v. case management with a low-income Spanish-speaking population.

C Telles1, M Karno, J Mintz, G Paz, M Arias, D Tucker, S Lopez.   

Abstract

BACKGROUND: This investigation compared the effectiveness and cross-cultural applicability of behavioural family management (BFM) and standard case management in preventing exacerbation of symptoms and relapse in schizophrenia.
METHOD: Forty low-income Spanish-speaking people with a diagnosis of schizophrenia were randomly assigned to receive standard case management or behavioural family management after stabilisation with neuroleptic medication.
RESULTS: Survival analyses indicated that among the less acculturated patients BFM was significantly related to greater risk of exacerbation of symptoms. Among the more acculturated patients, risk of exacerbation could be predicted by medication compliance but not by type of intervention. In analyses of symptom severity and functional status at 1-year follow-up, the level of patient acculturation was found to be significantly related to various measures of treatment outcome.
CONCLUSION: Sociocultural factors affect responses to different types of intervention. The results did not support earlier findings of a beneficial effect of BFM when applied to a socioculturally diverse population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8829715     DOI: 10.1192/bjp.167.4.473

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  26 in total

1.  Staff training in cognitive-behavioral family intervention in mental illness using the multiple-family group approach: a pilot study.

Authors:  R E Laube; F M Higson
Journal:  Community Ment Health J       Date:  2000-10

2.  Reflections on the Surgeon General's Report on Mental Health, Culture, Race, and Ethnicity.

Authors:  Steven Regeser López
Journal:  Cult Med Psychiatry       Date:  2003-12

3.  The importance of consumer perceived criticism on clinical outcomes for outpatient African Americans with schizophrenia.

Authors:  Joseph Guada; Maanse Hoe; Reta Floyd; Jack Barbour; John S Brekke
Journal:  Community Ment Health J       Date:  2010-12-05

Review 4.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

5.  Family interventions for mental disorders: efficacy and effectiveness.

Authors:  Ian R H Falloon
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

6.  Expressed emotion and sociocultural moderation in the course of schizophrenia.

Authors:  Adrian Aguilera; Steven R López; Nicholas J K Breitborde; Alex Kopelowicz; Roberto Zarate
Journal:  J Abnorm Psychol       Date:  2010-11

7.  The questionnaire of family functioning: a preliminary validation of a standardized instrument to evaluate psychoeducational family treatments.

Authors:  Rita Roncone; Monica Mazza; Donatella Ussorio; Rocco Pollice; Ian R H Falloon; Pierluigi Morosini; Massimo Casacchia
Journal:  Community Ment Health J       Date:  2007-07-06

Review 8.  State of the science on psychosocial interventions for ethnic minorities.

Authors:  Jeanne Miranda; Guillermo Bernal; Anna Lau; Laura Kohn; Wei-Chin Hwang; Teresa LaFromboise
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

Review 9.  Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review.

Authors:  Nicole M Lanouette; David P Folsom; Andres Sciolla; Dilip V Jeste
Journal:  Psychiatr Serv       Date:  2009-02       Impact factor: 3.084

10.  Evaluation of a Culturally Tailored Skills Intervention for Latinos with Persistent Psychotic Disorders.

Authors:  Brent T Mausbach; Jesus Bucardo; Veronica Cardenas; Christine L McKibbin; Concepcion Barrio; Sherrill R Goldman; Dilip V Jeste; Thomas L Patterson
Journal:  Am J Psychiatr Rehabil       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.